PathoGene

Los Angeles, United States

MedTech startup developing an automated IVD medical device for detecting and identifying all human pathogens & AMR genes on one test panel.

$500K raised

Jul 2021

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PathoGene raised?

PathoGene has raised $500K in total funding. The most recent round was Seed. The last funding was announced in July 2021.

Who are PathoGene's investors?

PathoGene's investors include Joseph Mickel.

Where is PathoGene headquartered?

PathoGene is headquartered in Los Angeles, United States.

What does PathoGene do?

MedTech startup developing an automated IVD medical device for detecting and identifying all human pathogens & AMR genes on one test panel.

What stage is PathoGene at?

PathoGene is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 14, 2021.

MLA

"PathoGene — Funding & Investors." VCBacked, July 14, 2021, https://www.vcbacked.co/company/pathogene. Accessed July 2, 2026.

APA

VCBacked. (2021). PathoGene — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/pathogene

Wikipedia (cite web)

{{cite web |title=PathoGene — Funding & Investors |url=https://www.vcbacked.co/company/pathogene |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 14, 2021.